Status:
TERMINATED
Reframing Needle-related Pain
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
Alberta Children's Hospital Research Institute
Solutions for Kids in Pain
Conditions:
Pain, Procedural
Eligibility:
All Genders
4-11 years
Phase:
NA
Brief Summary
The present research study aims to examine the efficacy of a brief parent-led memory reframing intervention to foster more adaptive (i.e., more accurate and positive) pain memories and less future nee...
Detailed Description
Pain is a common experience in childhood. Healthy children who adhere to recommended medical care undergo up to 20 painful procedures by the age of 5. Pain from, and fear of, medical experiences are n...
Eligibility Criteria
Inclusion
- A child will be eligible to participate if they
- are aged between 4 and 11 years old at the time of the recruitment;
- plan to receive a two-dose COVID-19 vaccine;
- are able to understand and speak English;
- have at least one of their caregivers' consent to participate in the study, and this caregiver is able to speak and read English
- have Internet access.
Exclusion
- serious developmental disabilities (e.g., Autism Spectrum Disorder) or speech/language delays, as it may make it difficult for the participants to complete all necessary study tasks (e.g., assent, memory interview);
- child's or caregiver's inability to speak and/or understand English
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 27 2023
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT05217563
Start Date
February 1 2022
End Date
January 27 2023
Last Update
February 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alberta Children's Hospital
Calgary, Alberta, Canada, T3B 6A8